Last Updated: May 10, 2026

Annora Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ANNORA

ANNORA has sixty-one approved drugs.

There are eight tentative approvals on ANNORA drugs.

Summary for Annora
US Patents:0
Tradenames:52
Ingredients:52
NDAs:61
Patent Litigation for Annora: See patent lawsuits for Annora

Drugs and US Patents for Annora

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Annora Pharma PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride SUPPOSITORY;RECTAL 216446-002 Nov 2, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma ELETRIPTAN HYDROBROMIDE eletriptan hydrobromide TABLET;ORAL 219143-001 Jul 7, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 212277-002 Jul 8, 2019 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma PIOGLITAZONE HYDROCHLORIDE pioglitazone hydrochloride TABLET;ORAL 204133-003 Apr 7, 2014 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma VIGABATRIN vigabatrin FOR SOLUTION;ORAL 213519-001 Jan 26, 2021 AA RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma SOLIFENACIN SUCCINATE solifenacin succinate TABLET;ORAL 215761-002 Jun 15, 2022 AB RX No No ⤷  Start Trial ⤷  Start Trial
Annora Pharma PANTOPRAZOLE SODIUM pantoprazole sodium FOR SUSPENSION, DELAYED RELEASE;ORAL 216139-001 Oct 27, 2023 AB RX No No ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.